Robert Bowes, MD
Obstetrics & Gynecology · Grand Rapids, MINPI 1588605372
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,677 of the $4,121 with a category attached, or 89.2%. 31 manufacturers reported payments, led by Hologic Sales And Service, LLC at 31.9% of the total. Reporting peaked in 2022 at $1,365 and has fallen 81.7% since, to $250 in 2025. Among obstetrics & gynecology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$1K
- AbbVie$727
- Momentis Surgical Inc.$500
- Astellas Pharma US Inc$239
- Gynesonics, Inc.$223
- Aspira Women's Health Inc$198
- plus $917 from 25 others
What the payments were for
- Travel & lodging$3428%
- Food & beverage$3,67789%
- Education$1012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 103 | $1,316 |
| AbbVie(2 entities) | 32 | $727 |
| Momentis Surgical Inc. | 4 | $500 |
| Astellas Pharma US Inc | 8 | $239 |
| Gynesonics, Inc. | 2 | $223 |
| Aspira Women's Health Inc | 5 | $198 |
| AMAG Pharmaceuticals, Inc. | 7 | $85 |
| Daiichi Sankyo Inc. | 5 | $83 |
| Bayer | 5 | $78 |
| Channel Medsystems, Inc. | 1 | $61 |
| Meditrina | 1 | $60 |
| Axonics, Inc. | 3 | $58 |
| Organon | 3 | $55 |
| Biogen | 2 | $45 |
| Pfizer | 2 | $40 |
| Myovant Sciences Inc. | 2 | $37 |
| Coloplast | 2 | $36 |
| Merck | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Minerva Surgical, Inc | 1 | $27 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Exeltis, USA Inc. | 2 | $24 |
| Medtronic | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| BD | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Coopersurgical, Inc. | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $12 |
| Roche Diagnostics Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,121 in reported general payments places this provider in the 90th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 45 | $47,302 |
| Estradiol | 71 | $7,458 |
| Estradiol (Twice Weekly)Estradiol | 18 | $2,945 |
| Solifenacin Succinate | 32 | $2,438 |
| ProgesteroneProgesterone, Micronized | 12 | $821 |
| Clobetasol Propionate | 11 | $149 |
| Triamcinolone Acetonide | 20 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $239 | $47,30245 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Other obstetrics & gynecology in Grand Rapids
- Gregory GresselGrand Rapids$85K
- Robyn HubbardGrand Rapids$73K
- Diana BitnerGrand Rapids$58K
- Stephen DalmGrand Rapids$48K
- Vivian Romero RomeroGrand Rapids$19K
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.